Eli Lilly Warns of Limited Tariff Impact on Pharmaceutical Industry
Eli Lilly is preparing for potential tariffs on pharmaceuticals amid an investigation into national security threats from overseas drug manufacturing. The company’s CEO, David Ricks, met with President Trump in recent weeks to discuss the matter. Ricks stated that while there is a threat, it is currently limited and can be absorbed within the 2025 … Read more